Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5328
Gene Symbol: PLAU
PLAU
0.300 Biomarker disease CTD_human
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE Direct sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene in 14 families with familial early onset Alzheimer's disease without the known pathogenic mutation (APP717) failed to reveal other mutations within the beta-amyloid sequence in this form of the disorder. 1791986 1991
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE Screening for the beta-amyloid precursor protein mutation (APP717: Val----Ile) in extended pedigrees with early onset Alzheimer's disease. 1922963 1991
Entrez Id: 351
Gene Symbol: APP
APP
0.500 Biomarker disease CTD_human Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. 1678058 1991
Entrez Id: 351
Gene Symbol: APP
APP
0.500 Biomarker disease CTD_human Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. 1671712 1991
Entrez Id: 351
Gene Symbol: APP
APP
0.500 Biomarker disease CTD_human Vitamin E protects nerve cells from amyloid beta protein toxicity. 1497677 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE Four mutations involving amino acid substitutions in exons 16 and 17 of the amyloid precursor protein (APP) gene, have been identified which co-segregate with the disease in some families multiply affected by early onset Alzheimer's disease. 1365885 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease CLINVAR More missense in amyloid gene. 1303275 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE This result strongly suggests that the missense mutations at codon 717 produce AD by altering the amino acid sequence of APP rather than the IRE. 1619445 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE These data suggest that mutations in APP are a rare cause of familial early onset AD (3/21 families tested) and that within APP most, possibly all, mutations which cause AD are in exon 17. 1303172 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. 1302033 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE Although mutations in the beta-amyloid precursor protein gene (APP) on chromosome 21 cause some cases of early-onset Alzheimer's disease (AD), most cases evidently do not have mutations in APP. 1303291 1992
Entrez Id: 351
Gene Symbol: APP
APP
0.500 AlteredExpression disease BEFREE These include the possibilities that mice are incapable of developing AD for reasons dependent on their APP sequence; and that appropriate regulation of APP gene is required for pathology to develop. 8117426 1993
Entrez Id: 348
Gene Symbol: APOE
APOE
0.500 Biomarker disease CTD_human Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 8346443 1993
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE Pathogenic mutations have been identified in exons 16 and 17 of the beta-amyloid precursor protein (APP) gene in some cases of early onset Alzheimer's disease. 8469399 1993
Entrez Id: 351
Gene Symbol: APP
APP
0.500 Biomarker disease BEFREE It is localised with the beta-amyloid peptide in the arterial walls of AD brains. 8361651 1993
Entrez Id: 1471
Gene Symbol: CST3
CST3
0.310 Biomarker disease BEFREE We conclude that the deposition of Cystatin-C in AD is a secondary event in the disease process, and that this gene is not pathogenic in familial AD. 8361651 1993
Entrez Id: 2147
Gene Symbol: F2
F2
0.300 Biomarker disease CTD_human Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. 8333868 1993
Entrez Id: 348
Gene Symbol: APOE
APOE
0.500 Biomarker disease BEFREE Our study demonstrates a significant association between APOE*4 and EOAD which is modified by family history of dementia. 8075646 1994
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-->T change at position 2149 of the amyloid precursor protein gene. 8290042 1994
Entrez Id: 4129
Gene Symbol: MAOB
MAOB
0.300 Biomarker disease CTD_human Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. 7816197 1994
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.010 GeneticVariation disease BEFREE Candidates include the choroid plexus transport protein, transthyretin at 18q11.2-q12.1; the t(14;18)(q22;21) characterizing B-cell lymphoma-2, the most common form of hematologic cancer; and the 14q24 locus of early onset Alzheimer's disease, c-Fos, transforming growth factor beta 3, and heat shock protein A2. 7810588 1994
Entrez Id: 348
Gene Symbol: APOE
APOE
0.500 GeneticVariation disease BEFREE In our population, there was no evidence for a protective effect of the APOE*2 allele on the risk of EOAD. 7755355 1995
Entrez Id: 348
Gene Symbol: APOE
APOE
0.500 GeneticVariation disease BEFREE Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. 8525799 1995
Entrez Id: 351
Gene Symbol: APP
APP
0.500 GeneticVariation disease BEFREE In some families with early-onset Alzheimer's disease (AD) pathogenic mutations have been found in exons 16 and 17 of the amyloid precursor protein (APP) gene. 7724053 1995